Chinese Journal of Pharmacovigilance ›› 2025, Vol. 22 ›› Issue (4): 436-441.
DOI: 10.19803/j.1672-8629.20240557

Previous Articles     Next Articles

Pharmacovigilance for Traditional Chinese Patent Medicines for Orthopedics

YANG Jingqi1, XU Baohai1, ZHANG Jing1, JIANG Yang2, SHI Fang2   

  1. 1Pharmacy of Traditional Chinese Medicine, Beijing Jishuitan Hospital, Capital Medical University, Beijing 100035, China;
    2Department of TCM, Beijing Jishuitan Hospital, Capital Medical University, Beijing 100035, China
  • Received:2024-08-12 Published:2025-04-17

Abstract: Objective To trace medications with traditional Chinese patent medicines used in orthopedics departments in three locations of Beijing Jishuitan Hospital in 2024 and analyze the information related to pharmacovigilance so as to ensure rational and safe medications. Methods Data on usage of drugs was analyzed based on reports on adverse drug reactions, the hospital information management system and drug instructions. Cases of ADR caused by traditional Chinese patent medicines for orthopedics, data on drug contraindications, and toxic ingredients were statistically analyzed. Results ADR due to Traditional Chinese patent medicines in the orthopedics department were more prevalent in females or middle-aged and elderly people. The systems-organs involved were mostly the skin, nerves and the digestive system. Information about drug contraindications involved special populations, disease syndromes, diet and combined medications. Traditional Chinese patent medicines containing toxic components used by the orthopedics department accounted for 45.31% of the total, with aconitum as the dominating toxic component. Conclusion Traditional Chinese patent medicines are frequently used in orthopedics. There is a wide range of contraindications, and most of the drugs for orthopedics contain toxic ingredients, so pharmacovigilance is required.

Key words: Orthopedics, Traditional Chinese Patent Medicines, Aconitum, Adverse Drug Reaction, Special Populations, Toxic Components, Pharmacovigilance

CLC Number: